These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5496796)

  • 1. [Rifampicin and liver function (72 punctures biopsies)].
    Taranger J; Girbal JP; Giacchero G
    Rev Tuberc Pneumol (Paris); 1970; 34(5):717-20. PubMed ID: 5496796
    [No Abstract]   [Full Text] [Related]  

  • 2. [Microscopic changes in liver in experimental tuberculosis in guinea pigs treated with rifampicin].
    Westfal I; Zengteler G; Szymaczek-Meyer L
    Gruzlica; 1974 Sep; 42(9):879-85. PubMed ID: 4410147
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse reactions during rifampicin treatment.
    Riska N; Mattson K
    Scand J Respir Dis; 1972; 53(2):87-96. PubMed ID: 5052728
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on short-course chemotherapy of tuberculosis. II. Liver function during 6-month chemotherapy of tuberculosis with hydrazide, rifampicin and pyrazinamide].
    Nikodemowicz E; Kamińska M; Caban M; Struzik T
    Pneumonol Pol; 1984 Oct; 52(10):503-12. PubMed ID: 6533580
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rifampicin].
    Midtvedt T
    Tidsskr Nor Laegeforen; 1969 Dec; 89(24):1913-4. PubMed ID: 5377185
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R; Arioli V; Furesz S; Bolzoni G
    Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of the effect of rifampicin on the liver.
    Laudano OM
    Tijdschr Gastroenterol; 1973; 16(4):283-94. PubMed ID: 4742775
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates.
    Kisa O; Albay A; Bedir O; Baylan O; Doganci L
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):284-8. PubMed ID: 12661845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: concurrent bacterial eradication and acquisition of resistance.
    Liu Y; Cui J; Wang R; Wang X; Drlica K; Zhao X
    J Antimicrob Chemother; 2005 Dec; 56(6):1172-5. PubMed ID: 16207765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection.
    Garca-Doval I
    J Am Acad Dermatol; 2004 May; 50(5):801; author reply 801-2. PubMed ID: 15097974
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rifampicin and hepatic puncture biopsy].
    Bonneau H; Girbal JP; Alibert R; Varette I; Taranger J; Chambourlier P
    Mars Med; 1970; 107(10):800-1. PubMed ID: 5476974
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects.
    Kiuchi T; Tanaka K; Inomata Y; Uemoto S; Satomura K; Egawa H; Uyama S; Sano K; Okajima H; Yamaoka Y
    Transplant Proc; 1996 Dec; 28(6):3171-2. PubMed ID: 8962229
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifampin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):151-4. PubMed ID: 18486058
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between steady-state plasma concentration of antituberculous drugs and age, inclusion of rifampicin in the treatment regimen, adverse drug reactions and other clinical parameters.
    Woo J; Chan C; Chan R; Cheung W; Or K; Chan K
    J Med; 1995; 26(5-6):279-94. PubMed ID: 8721904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Rifampicin and the pill.
    Cohn HD
    JAMA; 1974 May; 228(7):828. PubMed ID: 4406296
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption.
    Ellard GA; Fourie PB
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S301-8; discussion S317-21. PubMed ID: 10593709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN].
    Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacology--toxicology: introductory remarks on rifampicin.
    Freerksen E
    Acta Tuberc Pneumol Belg; 1969; 60(3):255-7. PubMed ID: 5371661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.